Biological Process
| associative learning | | IEA | Ensembl:ENSMUSP00000063276 | 2290271 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
| behavioral fear response | | IEA | Ensembl:ENSMUSP00000063276 | 2290271 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
| brain development | | IEA | Ensembl:ENSRNOP00000014573 | 2290271 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
| chloride transport | | IEA | InterPro:IPR005435 | 2290271 | GO_REF:0000002 | InterPro | GO_REF:0000002 |
| cochlea development | | IEA | Ensembl:ENSMUSP00000063276 | 2290271 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
| gamma-aminobutyric acid signaling pathway | | IEA | InterPro:IPR005435 | 2290271 | GO_REF:0000002 | InterPro | GO_REF:0000002 |
| inner ear receptor cell development | | IEA | Ensembl:ENSMUSP00000063276 | 2290271 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
| innervation | | IEA | Ensembl:ENSMUSP00000063276 | 2290271 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
| ion transmembrane transport | | TAS | | 2290271 | Reactome:REACT_25300 | Reactome | Reactome:REACT_25300 |
| ion transmembrane transport | | TAS | | 2290271 | Reactome:REACT_25387 | Reactome | Reactome:REACT_25387 |
| sensory perception of sound | | IEA | Ensembl:ENSMUSP00000063276 | 2290271 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
| signal transduction | | TAS | | 2290271 | PMID:1321750 | PINC | PMID:1321750 |
| synaptic transmission | | IEA | Ensembl:ENSRNOP00000014573 | 2290271 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
| synaptic transmission | | TAS | | 2290271 | Reactome:REACT_13685 | Reactome | Reactome:REACT_13685 |
| synaptic transmission | | TAS | | 2290271 | Reactome:REACT_13477 | Reactome | Reactome:REACT_13477 |
| transmembrane transport | | TAS | | 2290271 | Reactome:REACT_15518 | Reactome | Reactome:REACT_15518 |
| transport | | TAS | | 2290271 | PMID:1321750 | PINC | PMID:1321750 |
Cellular Component
| cell junction | | IEA | UniProtKB-KW:KW-0965 | 2290271 | GO_REF:0000037 | UniProtKB | GO_REF:0000037 |
| chloride channel complex | | IEA | UniProtKB-KW:KW-0869 | 2290271 | GO_REF:0000037 | UniProtKB | GO_REF:0000037 |
| dendrite | | IEA | Ensembl:ENSMUSP00000063276 | 2290271 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
| dendrite | | IEA | Ensembl:ENSRNOP00000014573 | 2290271 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
| integral to membrane | | IEA | InterPro:IPR005435|InterPro:IPR006201 | 2290271 | GO_REF:0000002 | InterPro | GO_REF:0000002 |
| integral to membrane | | IEA | InterPro:IPR006201|InterPro:IPR018000 | 2290271 | GO_REF:0000002 | InterPro | GO_REF:0000002 |
| integral to membrane | | IEA | InterPro:IPR006201 | 2290271 | GO_REF:0000002 | InterPro | GO_REF:0000002 |
| integral to plasma membrane | | TAS | | 2290271 | PMID:1321750 | PINC | PMID:1321750 |
| neuronal cell body membrane | | IEA | Ensembl:ENSRNOP00000014573 | 2290271 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
| plasma membrane | | TAS | | 2290271 | Reactome:REACT_25130 | Reactome | Reactome:REACT_25130 |
| postsynaptic membrane | | IEA | UniProtKB-SubCell:SL-0219 | 2290271 | GO_REF:0000039 | UniProtKB | GO_REF:0000039 |
| postsynaptic membrane | | IEA | InterPro:IPR018000 | 2290271 | GO_REF:0000002 | InterPro | GO_REF:0000002 |
| receptor complex | | IEA | Ensembl:ENSRNOP00000014573 | 2290271 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
Molecular Function
| chloride channel activity | | IEA | UniProtKB-KW:KW-0869 | 2290271 | GO_REF:0000037 | UniProtKB | GO_REF:0000037 |
| extracellular ligand-gated ion channel activity | | IEA | InterPro:IPR006202|InterPro:IPR018000 | 2290271 | GO_REF:0000002 | InterPro | GO_REF:0000002 |
| extracellular ligand-gated ion channel activity | | IEA | InterPro:IPR006202 | 2290271 | GO_REF:0000002 | InterPro | GO_REF:0000002 |
| GABA receptor binding | | IEA | Ensembl:ENSRNOP00000014573 | 2290271 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
| GABA-A receptor activity | | IEA | Ensembl:ENSRNOP00000014573 | 2290271 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
| ion channel activity | | IEA | InterPro:IPR001390 | 2290271 | GO_REF:0000002 | InterPro | GO_REF:0000002 |
| receptor activity | | TAS | | 2290271 | PMID:1321750 | PINC | PMID:1321750 |
| transporter activity | | TAS | | 2290271 | PMID:1321750 | PINC | PMID:1321750 |
| 2299958 | PRSTS330_H | Prostate tumor susceptibility QTL 330 (human) | 1.02 | .0151 | Prostate tumor susceptibility | | 15 | 5260818 | 31260818 | Human |
| 2292947 | PRSTS130_H | Prostate tumor susceptibility QTL 130 (human) | 2.68 | | Prostate tumor susceptibility | | 15 | 12130899 | 38130899 | Human |
| 2293004 | PRSTS125_H | Prostate tumor susceptibility QTL 125 (human) | 2.21 | | Prostate tumor susceptibility | | 15 | 12130899 | 38130899 | Human |
| 1643445 | SLIPL19_H | Serum lipid level QTL 19 (human) | 2.3 | .36 | Lipid level | | 15 | 12680120 | 38680120 | Human |
| 2292774 | PRSTS104_H | Prostate tumor susceptibility QTL 104 (human) | 4.76 | | Prostate tumor susceptibility | | 15 | 14849787 | 40849787 | Human |
| 2292812 | PRSTS100_H | Prostate tumor susceptibility QTL 100 (human) | 3.49 | .005 | Prostate tumor susceptibility | | 15 | 14849787 | 40849787 | Human |
| 2292897 | PRSTS103_H | Prostate tumor susceptibility QTL 103 (human) | 4.05 | | Prostate tumor susceptibility | | 15 | 14849787 | 40849787 | Human |
| 2293472 | PRSTS296_H | Prostate tumor susceptibility QTL 296 (human) | | .027 | Prostate tumor susceptibility | | 15 | 14849787 | 40849787 | Human |
| 2293469 | PRSTS297_H | Prostate tumor susceptibility QTL 297 (human) | | .029 | Prostate tumor susceptibility | | 15 | 16869523 | 42869523 | Human |
| 1643521 | BW295_H | Body Weight QTL 295 (human) | 1.49 | | Body weight | BMI | 15 | 18260718 | 44260718 | Human |
| 2289303 | BW394_H | Body weight QTL 394 (human) | 1.49 | | Body weight | BMI | 15 | 18260718 | 44260718 | Human |
| 1643518 | BW267_H | Body Weight QTL 267 (human) | 1.6 | .00308 | Body weight | body mass index | 15 | 18491570 | 44491570 | Human |
| 2293465 | PRSTS285_H | Prostate tumor susceptibility QTL 285 (human) | | | Prostate tumor susceptibility | | 15 | 20090462 | 46090462 | Human |
| 2293482 | PRSTS306_H | Prostate tumor susceptibility QTL 306 (human) | | .001 | Prostate tumor susceptibility | | 15 | 20090462 | 46090462 | Human |
| 2293364 | PRSTS266_H | Prostate tumor susceptibility QTL 266 (human) | | | Prostate tumor susceptibility | | 15 | 20250762 | 46250762 | Human |
| 2293382 | PRSTS267_H | Prostate tumor susceptibility QTL 267 (human) | | | Prostate tumor susceptibility | | 15 | 20250762 | 46250762 | Human |
| 2293405 | PRSTS268_H | Prostate tumor susceptibility QTL 268 (human) | | | Prostate tumor susceptibility | | 15 | 20250762 | 46250762 | Human |
| 2289410 | BW327_H | Body weight QTL 327 (human) | 3.32 | .0001 | Body fat amount | | 15 | 20272334 | 46272334 | Human |
| 2289420 | BW314_H | Body weight QTL 314 (human) | 2.72 | .0003 | Body weight | lean mass | 15 | 20272334 | 46272334 | Human |
| 2289430 | BMD7_H | Bone mineral density QTL 7 (human) | 3.32 | .0001 | Bone mineral density | | 15 | 20272334 | 46272334 | Human |
| 1559341 | BW46_H | Body weight QTL 46 (human) | 1.87 | .004 | Body weight | body mass index | 15 | 20737849 | 46737849 | Human |
| 2316726 | GLUCO284_H | Glucose level QTL 284 (human) | 1.5 | .00753 | Glucose level | | 15 | 20737849 | 46737849 | Human |
| 1643523 | BW284_H | Body Weight QTL 284 (human) | 1.95 | .0013 | Body weight | | 15 | 22084112 | 48084112 | Human |
| 2289247 | BW146_H | Body weight QTL 146 (human) | 2.53 | .0003 | Body weight | BMI | 15 | 25130800 | 66560180 | Human |
| 2314739 | GLUCO86_H | Glucose level QTL 86 (human) | .8 | .01 | Glucose level | non-insulin dependent | 15 | 26007629 | 52007629 | Human |
| 1558700 | HRV1_H | Heart rate variability QTL 1 (human) | 1.84 | | Heart rate variability | very low-frequency power | 15 | 26219975 | 94521997 | Human |
| 1559411 | SCL107_H | Serum cholesterol level QTL 107 (human) | 3.88 | | Lipid level | triglyceride | 15 | 26788693 | 31260818 | Human |
| 1643273 | BW330_H | Body Weight QTL 330 (human) | 1.05 | .014 | Body weight | body mass index | 15 | 27111866 | 31260818 | Human |